Advanced search
Publication Cover
Journal of Investigative Surgery Volume 33, 2020 - Issue 4
Submit an article Journal homepage
60
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma

Sam GriggDepartment of Medicine, University of Melbourne, Parkville, Victoria, Australia; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6116-6595
ORCID Icon,
Paul GowLiver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia
&
Neville YeomansDepartment of Medicine, University of Melbourne, Parkville, Victoria, Australia; ORCID Iconhttps://orcid.org/0000-0001-9870-832X
ORCID Icon
Pages 389-390 | Published online: 20 Nov 2018

References

  • Zhang Z-H, Li LX, Li P, Lv S-C, Pan B, He Q. Sirolimus in liver transplant recipients with hepatocellular carcinoma: an updated meta-analysis. J Invest Surg. 2018;1. doi: 10.1080/08941939.2018.1447053.
  • Vivarelli M, Dazzi A, Zanello M, et al. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010; 89(2):227–231.
  • Zhao X, Lu S, Wang M, et al. A retrospective cohort study regarding the effect of sirolimus-based immunosuppression protocol on the long-term survival of hepatocellular carcinoma patients after liver transplantation. Zhonghua Wai Ke Za Zhi 2014;52(4):245–248.
  • Xu S-L, Zhang Y-C, Wang G-Y, et al. Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2016;40(6):674–681.
  • Chinnakotla S, Davis GL, Vasani S, et al. Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl. 2009;15(12):1834–1842.
  • Zimmerman MA, Trotter JF, Wachs M, et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl. 2008;14(5):633–638.
  • Toso C, Merani S, Bigam DL, Shapiro AMJ, Kneteman NM. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology 2010;51(4):1237–1243.
  • Yanik EL, Chinnakotla S, Gustafson SK, et al. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma. Liver Transpl. 2016;22(5):627–634.
  • Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to Meta-Analysis. West Sussex: John Wiley & Sons; 2009.
  • Xu D-W, Wan P, Xia Q. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: a review. World J Gastroenterol. 2016;22(12):3325–3334.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.